Health Catalyst, Inc. (NASDAQ:HCAT)
| Market Cap | 130.05M-38.3% |
| Revenue (ttm) | 292.25M-7.5% |
| Net Income | -264.82M-164.5% |
| EPS | -3.68-143.7% |
| Shares Out | 73.89M |
| PE Ratio | n/a |
| Forward PE | 217.96 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 240,671 |
| Open | 1.73 |
| Previous Close | 1.77 |
| Day's Range | 1.72 - 1.78 |
| 52-Week Range | 0.95 - 3.62 |
| Beta | 1.54 |
| Analysts | Buy |
| Price Target | 1.77(+0.57%) |
| Earnings Date | Nov 9, 2026 |
Health Catalyst, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About HCAT
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$HCAT stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in HCAT holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by HCAT's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
HCAT Estimated quarterly lobbying spending
Source: U.S. Senate LDA
HCAT Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Recurring technology | $48.80M | 69.23% |
| Professional services | $21.69M | 30.77% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New HCAT patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to HCAT from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in HCAT
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $3.38M |
| VXFVanguard Extended Market ETF | $1.38M |
| FESMFidelity Enhanced Small Cap ETF | $829.36K |
| SCHASchwab U.S. Small-Cap ETF | $570.19K |
| IWCiShares Micro-Cap ETF | $320.92K |
| VHTVanguard Health Care ETF | $225.36K |
Estimated from each fund’s disclosed top holdings × AUM
HCAT Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from HCAT’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score